CN101167864A - Traditional Chinese medicinal formula for treating hyperosteogeny - Google Patents

Traditional Chinese medicinal formula for treating hyperosteogeny Download PDF

Info

Publication number
CN101167864A
CN101167864A CNA2007101140150A CN200710114015A CN101167864A CN 101167864 A CN101167864 A CN 101167864A CN A2007101140150 A CNA2007101140150 A CN A2007101140150A CN 200710114015 A CN200710114015 A CN 200710114015A CN 101167864 A CN101167864 A CN 101167864A
Authority
CN
China
Prior art keywords
grams
radix
root
traditional chinese
blood
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2007101140150A
Other languages
Chinese (zh)
Inventor
朱瑜琪
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNA2007101140150A priority Critical patent/CN101167864A/en
Publication of CN101167864A publication Critical patent/CN101167864A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to Chinese herbal medicine medicament for treating hyperostosis in the field of traditional Chinese medicine medicament. The technical scheme is that the invention comprises 60g prepared rehmannia root, 60g drynaria, 60g boiled strychnos nux-vomica, 60g spatholobus stem, 60g cristanche, 30g Chinese notoginseng, 30g net myrrh, 30g old ligusticum wallichii, 15g big levisticum, 15g dipsacus asper, 15g achyranthes bidentata blume, 30g erythrina bark, 18g western large-leaf gentian root, 10g Sichuan eucommia bark, 10g clematis chinensis, 10g whole Chinese angelica root, 10g megascolecidae, and 9g raw licorice root. The symptoms of the hyperostosis are diagnosed by the traditional Chinese medicine as deficiency of liver and kidney obstruction of blood circulation, and wind-cold by dampness is invaded into bones and muscles, qi and blood are stagnated, meridians are obstructed, and pathogenic factors and stasis are stagnated on spine. The invention is prepared towards to the symptoms of gyperostosis, and has the effects of replenishing liver and kidney, supplementing essence and marrow, strengthening muscles and bones, activating blood and dredging channels, dissolving detumescences and lumps, and activating blood and relieving pain. The prescription has accurate efficacy, and the curative rate reaches 87%, and the effect rate reaches 95%.

Description

The Chinese medicinal formulae of treatment bone matrix hyperplasia
Technical field
The present invention relates to a kind of Chinese medicinal formulae for the treatment of bone matrix hyperplasia of field of traditional Chinese.
Background technology
The special-purpose medicaments of treatment bone matrix hyperplasia is fewer at present, all is the plaster that adopts formulated among the people mostly.Regular several drugs is unsatisfactory at the curative effect of bone matrix hyperplasia, and the plaster of prescription among the people lacks codes and standards, is difficult to promote the use of.
Summary of the invention
Purpose of the present invention is exactly the defective that exists at prior art, and a kind of good effect is provided, and codes and standards are specially at the Chinese medicinal formulae of the treatment bone matrix hyperplasia of bone matrix hyperplasia.
Its technical scheme is: Radix Rehmanniae Preparata 60 grams, Rhizoma Drynariae 60 grams, Semen Strychni (processed) 60 grams, Caulis Spatholobi 60 grams, Herba Cistanches 60 grams, Radix Notoginseng 30 grams, clean Myrrha 30 grams, old Rhizoma Chuanxiong 30 grams, Rhizoma et Radix Araliae Cordatae 15 grams, Radix Dipsaci 15 grams, Radix Achyranthis Bidentatae 15 grams, Cortex erythrinae 30 grams, two Radix Gentianae Macrophyllae, 18 grams, Cortex Eucommiae 10 grams, Radix Clematidis 10 grams, Radix Angelicae Sinensis 10 grams, LUMBRICUS 10 grams, Radix Glycyrrhizae 9 grams.
The bone matrix hyperplasia differential diagnosis in tcm is: deficiency of the liver and kindey, blood-vessel obstructive.Wind-cold damp pathogen is attacked outside taking advantage of a weak point in opponent's defence, and invades muscles and bones, qi depression to blood stasis, and the passages through which vital energy circulates impatency, the pathogens agglomerating stasis of blood is coagulated vertebra.The present invention is exactly the liver and the kidney tonifying that has at this preparation, life essence-filling, marrow-benefitting, strengthening the tendons and bones, promoting blood circulation to remove obstruction in the collateral, dispersing swelling and dissipating binds, promoting blood circulation and stopping pain.This prescription determined curative effect, cure rate is up to 87%, and effective percentage reaches 95%.
The specific embodiment
Raw material is formed: Radix Rehmanniae Preparata 60 grams, Rhizoma Drynariae 60 grams, Semen Strychni (processed) 60 grams, Caulis Spatholobi 60 grams, Herba Cistanches 60 grams, Radix Notoginseng 30 grams, clean Myrrha 30 grams, old Rhizoma Chuanxiong 30 grams, Rhizoma et Radix Araliae Cordatae 15 grams, Radix Dipsaci 15 grams, Radix Achyranthis Bidentatae 15 grams, Cortex erythrinae 30 grams, two Radix Gentianae Macrophyllae, 18 grams, Cortex Eucommiae 10 grams, Radix Clematidis 10 grams, Radix Angelicae Sinensis 10 grams, LUMBRICUS 10 grams, Radix Glycyrrhizae 9 grams.
Using method is ground the above-mentioned raw materials medicine into powder making pellets by mixing medical powder with honey, and every ball weighs 6 grams, day clothes 2 times, and each 1 ball, eliminating cold for resuscitation water or yellow wine take.
Can certainly adopt existing Chinese patent medicine preparation technology to be processed into other for oral administration use of dosage form.

Claims (1)

1. a Chinese medicinal formulae for the treatment of bone matrix hyperplasia is characterized in that: Radix Rehmanniae Preparata 60 grams, Rhizoma Drynariae 60 grams, Semen Strychni (processed) 60 grams, Caulis Spatholobi 60 grams, Herba Cistanches 60 grams, Radix Notoginseng 30 grams, clean Myrrha 30 grams, old Rhizoma Chuanxiong 30 grams, Rhizoma et Radix Araliae Cordatae 15 grams, Radix Dipsaci 15 grams, Radix Achyranthis Bidentatae 15 grams, Cortex erythrinae 30 grams, RADIX GENTIANAE MACROPHYLLAE 18 grams, Cortex Eucommiae 10 grams, Radix Clematidis 10 grams, Radix Angelicae Sinensis 10 grams, LUMBRICUS 10 grams, Radix Glycyrrhizae 9 grams.
CNA2007101140150A 2007-10-28 2007-10-28 Traditional Chinese medicinal formula for treating hyperosteogeny Pending CN101167864A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNA2007101140150A CN101167864A (en) 2007-10-28 2007-10-28 Traditional Chinese medicinal formula for treating hyperosteogeny

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNA2007101140150A CN101167864A (en) 2007-10-28 2007-10-28 Traditional Chinese medicinal formula for treating hyperosteogeny

Publications (1)

Publication Number Publication Date
CN101167864A true CN101167864A (en) 2008-04-30

Family

ID=39388712

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2007101140150A Pending CN101167864A (en) 2007-10-28 2007-10-28 Traditional Chinese medicinal formula for treating hyperosteogeny

Country Status (1)

Country Link
CN (1) CN101167864A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102670839A (en) * 2012-04-25 2012-09-19 郭效德 External traditional Chinese medicine composition for treating hyperosteogeny
CN104666592A (en) * 2015-03-23 2015-06-03 曹燕欣 Traditional Chinese medicine composite for treating cervical spine bone hyperplasia and preparation method of traditional Chinese medicine composite
CN104906258A (en) * 2015-06-04 2015-09-16 张青怀 Traditional Chinese medicine for treating osteoproliferation
CN106822290A (en) * 2017-04-10 2017-06-13 任海 Treat the Chinese medicine composition of osteoproliferation

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102670839A (en) * 2012-04-25 2012-09-19 郭效德 External traditional Chinese medicine composition for treating hyperosteogeny
CN102670839B (en) * 2012-04-25 2013-07-17 郭效德 External traditional Chinese medicine composition for treating hyperosteogeny
CN104666592A (en) * 2015-03-23 2015-06-03 曹燕欣 Traditional Chinese medicine composite for treating cervical spine bone hyperplasia and preparation method of traditional Chinese medicine composite
CN104906258A (en) * 2015-06-04 2015-09-16 张青怀 Traditional Chinese medicine for treating osteoproliferation
CN106822290A (en) * 2017-04-10 2017-06-13 任海 Treat the Chinese medicine composition of osteoproliferation

Similar Documents

Publication Publication Date Title
CN100488549C (en) Externally applied medicament for treating rheumatism
CN101485836A (en) Oral capsule for treating neck, waist and leg pain diseases and preparation method thereof
CN103356854A (en) Traditional Chinese medicine for treating rheumatism
CN111840383A (en) Targeted spray moxibustion composition for treating rheumatic arthritis and preparation and use methods thereof
CN103705797B (en) A kind of medicine for the treatment of renal calculus
CN103721080A (en) Traditional Chinese medicine composition for treating cervical spondylosis, lumbar spondylosis and sciatica
CN101167864A (en) Traditional Chinese medicinal formula for treating hyperosteogeny
CN103356968B (en) Traditional Chinese medicine composition for treating endometriosis
CN104000893A (en) Traditional Chinese medicine oral liquid for treating rhinitis
CN1060391C (en) Traditional Chinese medicine for treating gynecological tumour
CN101612377A (en) Traditional Chinese medicine for treating rheumatism
CN103211886A (en) Medicament for treating rheumatic arthritis
CN102406870B (en) Medicament for treating rheumatic arthralgia
CN104383166A (en) Medicine for treating rheumatic lumbocrural pains and preparation method thereof
CN101342245A (en) Traditional Chinese medicine for treating rheumatism
CN101708292B (en) Chinese medicament for treating rheumatic and rheumatoid diseases
CN101138625A (en) Chinese medicine composition for treating omarthritis
CN103961671A (en) Chili-wild pepper-pepper rheumatism pain relieving solution
CN101099848A (en) Traditional Chinese medicine powder agent for treating rheumatic arthritis, rheumatoid arthritis and ostealgia
CN102327553A (en) Traditional Chinese medicine for treating pyogenic osteomyelitis
CN101757259A (en) Traditional Chinese medicine pill for tonifying kidney, invigorating blood circulation and stimulating menstrual flow
CN1186056C (en) medicine for treating hyperosteogeny
CN102743601A (en) Recovering and rheumatism-dissipating decoction
CN102949684B (en) Medicine formula for treating rheumatoid arthritis
CN101879213A (en) Honeyed pill preparation for treating rheumatic arthritis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20080430